The c-Src inhibitor eCF506 diminishes opioid tolerance and reduces β-arrestin2 recruitment.
- DOI
- 10.1111/bph.70647
- Published
- 2026 Aug 23
- Container
- British journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70647,
title = {The c-Src inhibitor eCF506 diminishes opioid tolerance and reduces β-arrestin2 recruitment.},
author = {Singleton S and Nunn F and Lace E and Lorente-Macías Á and Toth R and Unciti-Broceta A and Hales TG},
year = {2026},
journal = {British journal of pharmacology},
doi = {10.1111/bph.70647},
url = {https://doi.org/10.1111/bph.70647}
}RIS
TY - JOUR TI - The c-Src inhibitor eCF506 diminishes opioid tolerance and reduces β-arrestin2 recruitment. AU - Singleton S AU - Nunn F AU - Lace E AU - Lorente-Macías Á AU - Toth R AU - Unciti-Broceta A AU - Hales TG PY - 2026 JO - British journal of pharmacology DO - 10.1111/bph.70647 UR - https://doi.org/10.1111/bph.70647 ER -
APA
S, S., F, N., E, L., Á, L., R, T., A, U., & TG, H. (2026). The c-Src inhibitor eCF506 diminishes opioid tolerance and reduces β-arrestin2 recruitment.. British journal of pharmacology. https://doi.org/10.1111/bph.70647
Source records
- pubmed · retrieved 2026-09-25T05:10:06.296Z